US Patent Issued to Children's Medical Center on April 22 for "Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomopathies" (Massachusetts Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,064, issued on April 22, was assigned to Children's Medical Center Corp..

"Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomopathies" was invented by Leonard I. Zon (Wellesley, Mass.) and Alison M. Taylor (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to methods, compositions and kits for treatment of ribosomal disorders and ribosomopathy, e.g. Diamond Blackfan anemia (DBA). In some embodiments, the invention relates to methods for the use of calmodulin inhibitors and calcium channel blockers for treatment of ribosomal disorders and ribosomopathy, e.g. Diamond Blackfan...